[
  {
    "date": "2023-12-31",
    "symbol": "GLPG",
    "period": "FY",
    "documenttype": "20-F",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-37384",
    "entityregistrantname": "GALAPAGOS NV",
    "entityincorporationstatecountrycode": "C9",
    "entityaddressaddressline1": "Generaal De Wittelaan L11 A3",
    "entityaddresscityortown": "Mechelen",
    "entityaddresscountry": "BE",
    "entityaddresspostalzipcode": 2800,
    "contactpersonnelfaxnumber": "32 15 342 901",
    "contactpersonnelname": "Stoffels IMC BV (permanently represented by Dr. Paul Stoffels)",
    "security12btitle": "American Depositary Shares, each representing one",
    "securityexchangename": "NASDAQ",
    "tradingsymbol": "GLPG",
    "entitycommonstocksharesoutstanding": 65897071,
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1421876,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "auditorname": "BDO Bedrijfsrevisoren BV",
    "auditorfirmid": 1432,
    "auditorlocation": "Zaventem, Belgium",
    "amendmentflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "goodwill": 69557000,
    "intangibleassetsotherthangoodwill": 127906000,
    "propertyplantandequipmentincludingrightofuseassets": 4194000,
    "deferredtaxassets": 1126000,
    "noncurrentresearchanddevelopmentincentivesreceivables": 141252000,
    "othernoncurrentassets": 29645000,
    "noncurrentassets": 495807000,
    "inventories": 73978000,
    "tradeandothercurrentreceivables": 28449000,
    "currentresearchanddevelopmentincentivesreceivables": 37436000,
    "currentinvestments": 3517698000,
    "cashandcashequivalents": 166803000,
    "othercurrentassets": 15140000,
    "currentassetsotherthanassetsordisposalgroupsclassifiedasheldforsaleorasheldfordistributiontoowners": 3839504000,
    "noncurrentassetsordisposalgroupsclassifiedasheldforsale": 22085000,
    "currentassets": 3861589000,
    "assets": 4357396000,
    "issuedcapital": 293937000,
    "sharepremium": 2736994000,
    "otherreserves": -5890000,
    "reserveofexchangedifferencesontranslation": -1201000,
    "retainedearnings": -228274000,
    "equity": 2795566000,
    "noncurrentrecognisedliabilitiesdefinedbenefitplan": 2293000,
    "deferredtaxliabilities": 23607000,
    "noncurrentleaseliabilities": 4944000,
    "totalothernoncurrentliabilities": 31570000,
    "noncurrentdeferredincomeotherthannoncurrentcontractliabilities": 1071193000,
    "noncurrentliabilities": 1133607000,
    "currentleaseliabilities": 4652000,
    "tradeandothercurrentpayables": 135201000,
    "currenttaxliabilities": 56000,
    "currentdeferredincomeotherthancurrentcontractliabilities": 256270000,
    "currentliabilitiesotherthanliabilitiesincludedindisposalgroupsclassifiedasheldforsale": 396179000,
    "liabilitiesincludedindisposalgroupsclassifiedasheldforsale": 32044000,
    "currentliabilities": 428223000,
    "liabilities": 1561830000,
    "equityandliabilities": 4357396000,
    "revenuefromcollaboration": 239724000,
    "revenue": 239724000,
    "researchanddevelopmentexpense": 241294000,
    "salesandmarketingexpense": 5676000,
    "generalandadministrativeexpense": 128289000,
    "otheroperatingincomeexpense": 47272000,
    "profitlossfromoperatingactivities": -88263000,
    "fairvalueadjustmentsandnetcurrencyexchange": 16252000,
    "otherfinanceincome": 80249000,
    "otherfinancecost": 2613000,
    "profitlossbeforetax": 5625000,
    "incometaxexpensecontinuingoperations": 9613000,
    "profitlossfromcontinuingoperations": -3988000,
    "profitlossfromdiscontinuedoperations": 215685000,
    "profitloss": 211697000,
    "profitlossattributabletoownersofparent": 211697000,
    "basicearningslosspershare": 3.21,
    "dilutedearningslosspershare": 3.21,
    "basicearningslosspersharefromcontinuingoperations": -0.06,
    "weightedaverageshares": 65884000,
    "adjustedweightedaverageshares": 65933000,
    "othercomprehensiveincomenetoftaxgainslossesonremeasurementsofdefinedbenefitplans": -1037000,
    "gainslossesonexchangedifferencesontranslationnetoftax": 392000,
    "othercomprehensiveincome": -645000,
    "comprehensiveincomeattributabletoownersofparent": 211052000,
    "comprehensiveincomelossfromcontinuingoperations": -4564000,
    "comprehensiveincomelossfromdiscontinuedoperations": 215616000,
    "comprehensiveincome": 392000,
    "increasedecreasethroughsharebasedpaymenttransactions": 56718000,
    "increasedecreasethroughexerciseofwarrantsequity": 333000,
    "adjustmentfornoncashtransactions": 99291000,
    "adjustmentforitemstodiscloseseparatelyunderoperatingcashflow": -65763000,
    "otheradjustmentsforwhichcasheffectsareinvestingorfinancingcashflow": -16688000,
    "increasedecreaseinworkingcapitalexcludingdeferredincome": 31373000,
    "adjustmentsforincreasedecreaseindeferredincomeotherthancontractliabilities": -661062000,
    "cashflowsfromusedinoperations": -463898000,
    "interestpaidclassifiedasoperatingactivities": 3809000,
    "interestreceivedclassifiedasoperatingactivities": 69907000,
    "incometaxespaidrefundclassifiedasoperatingactivities": 8170000,
    "cashflowsfromusedinoperatingactivities": -405970000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 18706000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 567000,
    "proceedsfromsalesofpropertyplantandequipmentclassifiedasinvestingactivities": 2426000,
    "paymentstoacquirecurrentfinancialinvestments": 3390178000,
    "proceedsfrominterestreceivedrelatedtocurrentfinancialinvestments": 14765000,
    "proceedsfromsaleordisposalofcurrentfinancialinvestments": 3484411000,
    "cashflowsusedinobtainingcontrolofsubsidiariesorotherbusinessesclassifiedasinvestingactivities": 7000000,
    "purchaseofavailableforsalefinancialassets": 13965000,
    "cashflowsfromusedininvestingactivities": 71186000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 6771000,
    "proceedsfromexerciseofwarrants": 1770000,
    "cashflowsfromusedinfinancingactivities": -5001000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": -339785000,
    "cashandcashequivalentsincludingdiscontinuedoperations": 166810000,
    "effectofexchangeratechangesoncashandcashequivalents": -1522000,
    "numberofemployees": 1123,
    "numberofpersonnelrelatedtocontinuingoperations": 646,
    "upfrontpaymentreceived": 50000000,
    "upfrontpaymentsreceivable": 120000000,
    "costshareforglobaldevelopmentactivities": 0.5,
    "numberofdirectorsrepresentedasboardofdirectors": 2,
    "futureglobaldevelopmentcostssharingratiobeforepredeterminedlevel": 0.5,
    "weightedaverageexercisepriceofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement2019": 28.75,
    "proportionofownershipinterestinassociate": 0.2535,
    "commitmentsrelatedtodevelopmentactivities.": 40000000,
    "warrantvalue": 50000,
    "upfrontconsideration": 4018016000,
    "milestonesachievedamountoutstanding": 212601000,
    "revenuefromroyalties": 9466000,
    "royaltiesamountoutstanding": 40176000,
    "collaborationagreementconsiderationassharesubscription": 124604000,
    "transactionpriceallocatedtoremainingperformanceobligations": 4395397000,
    "warrantsissuanceliabilities": -43311000,
    "deferredincomeotherthancontractliabilities": 10140000,
    "collaborationagreementtotaltransactionprice": 9466000,
    "collaborationagreementestimatedsignificantfinancingcomponentvalue": 39800000,
    "purchasecommitmentrelatedtoservicesfromnovalix.": 63900000,
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": "P3Y",
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P33Y",
    "ifrsnumberofoperatingandreportablesegments": 1,
    "purchasecommitmentsterm": "P2Y",
    "remainingcosttocompleteperformanceobligationestimatedpercentage": 0.1,
    "increasedecreaseinrevenuerecognition": -2600000,
    "revenuefromsaleofgoods": 112339000,
    "costofsales": 18022000,
    "otherincome": 47272000,
    "deferredincomeincludingcontractliabilities": 26300000,
    "cashandcashequivalentsclassifiedaspartofdisposalgroupheldforsale": 7000,
    "othernoncurrentliabilities": 329000,
    "currenttaxliabilitiescurrent": 1242000,
    "netassetsliabilities": -9959000,
    "proportionofownershipinterestinsubsidiarysold": 1,
    "cashflowsfromusedinoperatingactivitiesdiscontinuedoperations": -175627000,
    "cashflowsfromusedininvestingactivitiesdiscontinuedoperations": -105000,
    "cashflowsfromusedinfinancingactivitiesdiscontinuedoperations": -1928000,
    "increasedecreaseincashandcashequivalentsdiscontinuedoperations": -177660000,
    "purchasecommitments": 6600000,
    "percentageofrevenuefromcollaborationpartnertototalrevenue": 1,
    "revenuefromcollaborationdiscontinuedoperations": 425466000,
    "totalcontinuedanddiscontinuedrevenuefromcollaboration": 665174000,
    "recognitionofnonrefundableupfrontpaymentsandlicensefees": 230242000,
    "periodoverwhichdrugdiscoveryprogramrevenueisrecognized": "P10Y",
    "maximumextensionperiodforspecificprogram": "P3Y",
    "researchanddevelopmentpersonnelcosts": 95788000,
    "researchanddevelopmentsubcontracting": 82997000,
    "researchanddevelopmentdisposablesandlabfeesandpremisescosts": 18083000,
    "researchanddevelopmentdepreciationexpenses": 22254000,
    "researchanddevelopmentprofessionalfeesexpenses": 9272000,
    "researchanddevelopmentotheroperatingexpenses": 12900000,
    "salesandmarketingpersonnelcosts": 2997000,
    "salesandmarketingdepreciationexpenses": 113000,
    "salesandmarketingexternaloutsourcingcosts": 1776000,
    "salesandmarketingprofessionalfeesexpenses": 131000,
    "salesandmarketingotheroperatingexpenses": 659000,
    "generalandadministrativepersonnelcostsanddirectorfees": 66098000,
    "generalandadministrativedepreciationexpenses": 15978000,
    "generalandadministrativelegalandprofessionalfees": 23250000,
    "generalandadministrativeotheroperatingexpenses": 22963000,
    "grantincome": 6618000,
    "researchanddevelopmentincentiveincome": 32968000,
    "miscellaneousotherincome": 7686000,
    "totalrdincentiveincome": 32968000,
    "incomefrominnovationincentivesysteminfrance": 5881000,
    "incomefrombelgianrdincentives.": 16535000,
    "taxrebatesonpayrollwithholdingtaxesofrdpersonnel": 10552000,
    "wagesandsalaries": 100250000,
    "socialsecuritycontributions": 15742000,
    "postemploymentbenefitexpensedefinedcontributionplansanddefinedbenefitplans": 5581000,
    "otherpersonnelcostswarrantsgranted": 36628000,
    "otheremployeeexpense": 6682000,
    "employeebenefitsexpense": 164883000,
    "numberofemployeesofcontinuingoperations.": 646,
    "averagenumberofemployees": 4,
    "netunrealizedcurrencyexchangegainotherfinancialincome": -20544000,
    "netrealizedcurrencyexchangegainotherfinancialincome": -1118000,
    "fairvalueremeasurementofwarrants": 18000,
    "gainslossesonfinancialassetsatfairvaluethroughprofitorloss": -390000,
    "fairvaluegainoncurrentfinancialinvestments": 38286000,
    "interestincomeondeposits": 79290000,
    "effectofdiscountinglongtermresearchanddevelopmentincentivesreceivables": 617000,
    "effectofdiscountingofothernoncurrentliabilities": 318000,
    "miscellaneousotherfinanceincome": 24000,
    "interestexpense": 1770000,
    "effectofdiscountinglongtermdeferredincome": -645000,
    "effectofdiscountingothernoncurrentliabilities": -318000,
    "miscellaneousotherfinanceexpense": 843000,
    "otherfinanceincomecost": 93888000,
    "currenttaxexpenseincome": 5928000,
    "deferredtaxexpenseincome": 3685000,
    "accountingprofit": 5625000,
    "taxexpenseincomeatapplicabletaxrate": 1406000,
    "differenceintaxexpenseincomebetweenstatutoryandeffectivetaxrate": 8207000,
    "taxeffectofforeigntaxrates": -94000,
    "taxeffectofrevenuesexemptfromtaxation2011": 6752000,
    "effectofsharebasedpaymentexpenseswithouttaximpact": 9157000,
    "taxeffectofconsolidationentrywithouttaximpact": -5000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 1549000,
    "taxeffectofrecognitionofpreviouslynonrecognizeddeferredtaxassets": -81000,
    "taxeffectfromtaxlossesutilizedreversed": -267000,
    "taxeffectfromunderoverprovisionpriorperiods": -722000,
    "taxeffectfromnonrecognitionofdeferredtaxassets": 34339000,
    "taxeffectofderecognitionofpreviouslyrecognizeddeferredtaxassets": 1062000,
    "taxeffectofuseofinnovationincomededuction": 29979000,
    "amountofdifferencesintaxexpenseincomebetweenstatutoryandeffectiverateexplained": 8207000,
    "applicabletaxrate": 0.25,
    "profitlossattributabletoordinaryequityholdersofparententity": 211697000,
    "dilutiveeffectofshareoptionsonnumberofordinaryshares": 49000,
    "increasedecreasethroughnetexchangedifferencesgoodwill": -256000,
    "explanationofperiodoverwhichmanagementhasprojectedcashflows": "P17Y",
    "descriptionofgrowthrateusedtoextrapolatecashflowprojections": -0.5,
    "descriptionofdiscountratesappliedtocashflowprojections": 0.1372,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 567000,
    "amortisationintangibleassetsotherthangoodwill": 4291000,
    "disposalsandretirementsintangibleassetsotherthangoodwill": 930000,
    "increasedecreasethroughnetexchangedifferencesintangibleassetsotherthangoodwill": -139000,
    "propertyplantandequipment": 90705000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 6754000,
    "disposalspropertyplantandequipment": 4403000,
    "increasedecreasethroughtransferspropertyplantandequipment": 95000,
    "decreasethroughclassifiedasheldforsalepropertyplantandequipment": 739000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": 279000,
    "depreciationsandimpairments": 4603000,
    "impairmentlossrecognisedinprofitorlosspropertyplantandequipment": 7645000,
    "propertyplantandequipmentfullyowned": 111220000,
    "rightofuseassets": 15101000,
    "noncurrentrestrictedcashandcashequivalents": 5533000,
    "noncurrentportionofupfrontpaymenttocounterpartyincollaborativearrangement": 4656000,
    "noncurrentportionofadvancemadetocounterpartyincollaborativearrangement": 5563000,
    "financialassetsatfairvaluethroughprofitorloss": 13575000,
    "othermiscellaneousnoncurrentassets": 318000,
    "financialassetsatamortisedcost": 2200893000,
    "researchanddevelopmentincentivesreceivables": 178688000,
    "rawmaterials": 55263000,
    "workinprogress": 12598000,
    "finishedgoods": 6117000,
    "currenttradereceivables": 17494000,
    "currentprepayments": 738000,
    "othercurrentreceivables": 10217000,
    "currentaccruedincomeotherthancurrentcontractassets": 508000,
    "deferredcharges": 14632000,
    "tradeandotherreceivablesandothercurrentasset": 43589000,
    "moneymarketfundsatcarryingvaluecurrent": 1316805000,
    "treasurybillsatcarryingvaluecurrent": 742025000,
    "noncancellabletermdeposits": 1458868000,
    "currentfinancialinvestmentssubjecttoforeigncurrencyexchangegainorloss": 830900000,
    "balanceswithbanks": 71803000,
    "shorttermdepositsclassifiedascashequivalents": 95000000,
    "maturityperiod": "P3M",
    "shorttermdepositlongerthanthreemonths": 50000000,
    "shorttermdepositlessthanthreemonths": 45000000,
    "amountofsharescapitalissuedandfullypaidamount": 293937000,
    "increasedecreaseinsharecapitalexcludingissuancepremium": 333000,
    "aggregatesharecapitalaftertransaction": 356445000,
    "accumulatedcostofcapital": 62507000,
    "increaseinsharecapitalduetoissuanceofwarrants": 333000,
    "numberofsharesissued": 62000,
    "aggregatenumberofsharesaftertransaction": 65897000,
    "numberofsharesissuedandfullypaid": 65897071,
    "numberofsharesissuedandfullypaidamount": 3030932000,
    "numberofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement": 61560,
    "closingsharepriceondateofcapitalincrease": 35.47,
    "parvaluepershare": 5.41,
    "futurefinancechargeonleaseliabilities": 214000,
    "authorizationtermofboardofdirectors": "P5Y",
    "remainingbalanceofgeneralpartofauthorizedcapitalavailable": 16566540.17,
    "deferredtaxliabilityasset": 159000,
    "deferredtaxexpenseincomerecognisedinprofitorloss": 1061000,
    "classifiedtoheldforsaledeferredtaxliabilityasset": -292000,
    "incometaxrelatingtocomponentsofothercomprehensiveincome": 132000,
    "increasedecreasethroughnetexchangedifferencesdeferredtaxliabilityasset": 8000,
    "taxattributesanddeductibletemporarydifferences": 1722200000,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 410000000,
    "taxlossescarriedforwardanddeductibletemporarydifferences": 1312200000,
    "deferredtaxassetwhenutilisationisdependentonfuturetaxableprofitsinexcessofprofitsfromreversaloftaxabletemporarydifferencesandentityhassufferedlossinjurisdictiontowhichdeferredtaxassetrelates": 798700000,
    "carriedforwardtaxdeductiontobeoffsetagainstfutureincome": 390300000,
    "unrecognizeddeferredtaxassets": 326800000,
    "leasepaymentspayableundernoncancelableoperatingleaseias17": 4779000,
    "leasepaymentspayableatpresentvalue": 4652000,
    "leaseliabilities": 9596000,
    "tradeandotherpayables": 134653000,
    "accrualsclassifiedascurrent": 548000,
    "totaltradeandotherliabilities": 135201000,
    "ifrsbusinesscombinationcontingentconsiderationliabilitynoncurrent": 20972000,
    "ifrstotalothernoncurrentliabilities": 31570000,
    "businesscombinationcontingentconsiderationliabilitymeasurementinputdiscountrate": 0.1372,
    "percentageofchangeinprobabilitiessuccess": 0.05,
    "impactoncontingentconsiderationliabilityofchangeinprobabilityofsuccess": 3000000,
    "deferredincomeotherthancontractliabilitiesreclassificationstoliabilitiesrelatedtoassetsheldforsale": -60000,
    "deferredincomesignificantfinancingcomponent": -645000,
    "upfrontorlicensefeesrevenuerecognised": -361412000,
    "milestonepaymentsrevenuerecognized": -68027000,
    "increasedecreaseinotherdeferredincome": -1382000,
    "cashusedforotherliabilitiesrelatedtoacquisitionofsubsidiariesfordeferredconsiderationpaymentclassifiedasoperatingactivities": 7000000,
    "numberofcd19cartproduct": 2,
    "ifrsdeferredtaxassetsgoodwillandintangibleassets": 9000000,
    "collaborationagreementtotalcommitment": 63900000,
    "collaborationagreementadvancestobereleasedcurrent": 2700000,
    "collaborationagreementadvancestobereleasednoncurrent": 5600000,
    "collaborationagreementremainingpurchasecommitmenttobereleasedcurrent": 2400000,
    "collaborationagreementremainingpurchasecommitmenttobereleasednoncurrent": 4700000,
    "depreciationsamortizationsandimpairment": 43642000,
    "adjustmentsforsharebasedpayments": 56718000,
    "adjustmentsforincreasedecreaseinemployeebenefitliabilities": 11000,
    "adjustmentsforunrealizedforeignexchangelossesgains": 19908000,
    "adjustmentsforfairvalueremeasurementofsharesubscriptionagreementandwarrants": -18000,
    "netfairvalueadjustmentrelatingtocurrentfinancialinvestments": -22690000,
    "adjustmentsforfairvaluegainslosses": 390000,
    "otheradjustmentsfornoncashitems": 2292000,
    "financecostspaidclassifiedasoperatingactivities": 1867000,
    "adjustmentsforinterestincome": 79319000,
    "adjustmentsforincometaxexpense": 11689000,
    "adjustmentsforgainlossondisposalspropertyplantandequipment": 1091000,
    "proceedsfrominterestincomecurrentfinancialinvestmentsinvestingandfinancingcashflows": -15597000,
    "adjustmentsfordecreaseincreaseininventories": -24076000,
    "adjustmentsfordecreaseincreaseintradeaccountreceivable": -39114000,
    "adjustmentsforincreasedecreaseintradeaccountpayable": 31817000,
    "purchasecommitmentsrelatedtoprojectsindevelopmentphase": 239600000,
    "purchasecommitmentrelatedtosharedservices": 45900000,
    "purchasecommitmentrelatedtojyselecaproductsupplychain": 14200000,
    "purchasecommitmentrelatedtocommercialandmedicalaffairs": 29900000,
    "purchasecommitmentrelatedtoprojectindiscoveryresearchphase": 79000000,
    "purchasecommitmentrelatedtoshorttermcontractualcostsharingobligations": 12300000,
    "commitmentswithpregene": 243500000,
    "ifrssharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod": "P36M",
    "percentageofotherequityinstrumentsvested": 0.00027,
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 20090000,
    "weightedaverageexercisepriceofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement2019": 28.75,
    "weightedaverageremainingcontractuallifeoutstandingofotherequityinstruments": "P1913D",
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 325500,
    "numberofinstrumentsotherequityinstrumentsgranted": 611000,
    "numberofotherequityinstrumentsexercisedinsharebasedpaymentarrangement": 61560,
    "numberofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement": 1663,
    "numberofotherequityinstrumentsexpiredinsharebasedpaymentarrangement": 241500,
    "numberofotherequityinstrumentsexercisableinsharebasedpaymentarrangement": 325500,
    "weightedaverageexercisepriceofotherequityinstrumentsgrantedinsharebasedpaymentarrangement2019": 35.53,
    "weightedaverageexercisepriceofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement2019": 80.31,
    "weightedaverageexercisepriceofotherequityinstrumentsexpiredinsharebasedpaymentarrangement2019": 49,
    "weightedaverageexercisepriceofotherequityinstrumentsexercisableinsharebasedpaymentarrangement2019": 101.93,
    "exercisepriceotherequityinstrumentsgranted": 35.97,
    "weightedaveragesharepriceatacceptancedate": 38.53,
    "weightedaveragefairvalueatacceptancedate": 16.61,
    "weightedaverageestimatedvolatilityrate": 0.3689,
    "weightedaverageexpectedlifeofsubscriptionrights": "P6Y1M20D",
    "weightedaverageriskfreerate": 0.0277,
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassetscontinuedoperations": 36628000,
    "numberofotherequityinstrumentspaidincashinsharebasedpaymentarrangement": 12163,
    "numberofsecuritiescalledbyeachrestrictedstockorright": 1,
    "numberofcalendardaysperiodprecedingvestingdateforcalculatevalueofweightedaveragepriceofentitysharetradedonstockexchange": 30,
    "percentageofotherequityinstrumentsvestedincertainperiod": 0.5,
    "numberofcalendardaysperiodprecedingreportingperiodforcalculatevalueofweightedaveragepriceofentitysharetradedonstockexchange": 30,
    "recognizedliabilityonrestrictedstockunits": 13800000,
    "numberofboardofdirectors": 2,
    "percentageofownershipinterest": 0.2535,
    "tradeandotherreceivablesrelatedpartytransactions": 5198000,
    "amountspayablerelatedpartytransactions": 585000,
    "crosschargesreceivablerelatingtodevelopmentoffilgotinib": 2500000,
    "royaltiesreceivablerelatingtodevelopmentoffilgotinib": 2400000,
    "totalimpactonrevenue": 429439000,
    "impactonrevenuesfromperformanceobligations": 230242000,
    "costreimbursementsrecognized": 299000,
    "numberofoutstandingperformanceobligations": 2,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 3902000,
    "keymanagementpersonnelcompensationboardfeesandothershorttermbenefitsfordirectors": 749000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 209000,
    "keymanagementpersonnelcompensationterminationbenefits": 3150000,
    "keymanagementpersonnelcompensationsharebasedpayment": 5163000,
    "proportionofvotingpowerheldinsubsidiary": 1,
    "financialassets": 166803000,
    "financialliabilities": 20972000,
    "currentfinancialinvestmentsandcashandcashequivalents": 3684500000,
    "percentageofreasonablypossibleincreaseinriskassumption": 0.01,
    "percentageofreasonablypossibledecreaseinriskassumption": 0.01,
    "increasedecreaseinprofitlossduetoreasonablypossibleincreaseinriskexposurethatarisesfromcontractswithinscopeofifrs17": 36800000,
    "increasedecreaseinprofitlossduetoreasonablypossibledecreaseinriskexposurethatarisesfromcontractswithinscopeofifrs17": 36800000,
    "percentageofreasonablypossiblechangeinriskassumption": 0.1,
    "increasedecreaseinnetbookvalueduetoreasonablypossiblechangeindesignatedriskcomponent": -78013000,
    "auditorsremunerationforauditservices": 1124000,
    "auditorsremunerationforlegalassignments": 20200,
    "otherfeesrelatedtononauditservicesexecutedbystatutoryauditor.": 6600,
    "professionalfeesexpense": 68000,
    "increaseinauditfeescomparedtoapprovedfees": 191300
  },
  {
    "date": "2020-12-31",
    "symbol": "GLPG",
    "period": "FY",
    "currenttaxexpenseincome": 1069000,
    "deferredtaxexpenseincome": 157000,
    "incometaxexpensecontinuingoperations": 1226000,
    "currentinvestments": 3026278000,
    "cashandcashequivalents": 2135187000,
    "cashandcashequivalentsclassifiedaspartofdisposalgroupheldforsale": 7884000,
    "currentfinancialinvestmentsandcashandcashequivalents": 5169349000,
    "recognitionofnonrefundableupfrontpaymentsandlicensefees": 411417000,
    "milestonepayments": 46261000,
    "reimbursementincome": 4073000,
    "otherrevenue": 70000,
    "revenuefromcommercialactivities": 16232000,
    "revenue": 478053000,
    "otherincome": 52207000,
    "revenueandoperatingincome": 530260000,
    "researchanddevelopmentexpense": 523667000,
    "salesandmarketingexpense": 66468000,
    "generalandadministrativeexpense": 118757000,
    "operatingexpense": 708892000,
    "profitlossfromoperatingactivities": -178632000,
    "gainslossesrecognisedinprofitorlossattributabletochangeinunrealisedgainsorlossesforentitysownequityinstrumentsheldatendofperiodfairvaluemeasurement": 3034000,
    "otherfinanceincome": 18667000,
    "otherfinancecost": 152844000,
    "profitlossbeforetax": -309775000,
    "profitlossfromcontinuingoperations": -311001000,
    "profitlossfromdiscontinuedoperations": 5565000,
    "profitloss": -305436000,
    "profitlossattributabletoownersofparent": -305436000,
    "basicearningslosspershare": -4.69,
    "dilutedearningslosspershare": -4.69,
    "basicearningslosspersharefromcontinuingoperations": -4.78,
    "dilutedearningslosspersharefromcontinuingoperations": -4.78,
    "weightedaverageshares": 65075,
    "adjustedweightedaverageshares": 67572,
    "othercomprehensiveincomenetoftaxgainslossesonremeasurementsofdefinedbenefitplans": -6065000,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -1024000,
    "othercomprehensiveincomenetoftaxtranslationdifferencesuponliquidationofforeignoperations": -1023000,
    "othercomprehensiveincome": -8112000,
    "comprehensiveincomeattributabletoownersofparent": -313548000,
    "comprehensiveincomelossfromcontinuingoperations": -318841000,
    "comprehensiveincomelossfromdiscontinuedoperations": 5293000,
    "financialassets": 5357438000,
    "financialliabilities": -3164000,
    "currentfinancialliabilities": 3164000,
    "otheradjustmentsfornoncashitems": 230723000,
    "otheradjustmentstoreconcileprofitloss": 4067000,
    "otheradjustmentsforwhichcasheffectsareinvestingorfinancingcashflow": -2472000,
    "increasedecreaseinworkingcapitalexcludingdeferredincome": 146092000,
    "adjustmentsforincreasedecreaseindeferredincome": -207787000,
    "cashflowsfromusedinoperations": -426998000,
    "interestpaidclassifiedasoperatingactivities": 9033000,
    "interestreceivedclassifiedasoperatingactivities": 10054000,
    "incometaxespaidrefundclassifiedasoperatingactivities": 1358000,
    "cashflowsfromusedinoperatingactivities": -427336000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 42522000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 48793000,
    "proceedsfromsalesofpropertyplantandequipmentclassifiedasinvestingactivities": 49000,
    "purchaseoffinancialinstrumentsclassifiedasinvestingactivities": 4574206000,
    "interestreceivedclassifiedasinvestingactivities": 3500000,
    "proceedsfromsalesormaturityoffinancialinstrumentsclassifiedasinvestingactivities": 5415316000,
    "purchaseofavailableforsalefinancialassets": 2681000,
    "proceedsfromdisposalormaturityofavailableforsalefinancialassets": 6626000,
    "cashflowsfromusedininvestingactivities": 757288000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 6247000,
    "proceedsfromexerciseofwarrants": 28287000,
    "cashflowsfromusedinfinancingactivities": 22040000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": 351994000,
    "cashandcashequivalentsifdifferentfromstatementoffinancialposition": 2143071000,
    "effectofexchangeratechangesoncashandcashequivalents": -70539000,
    "leaseliabilities": 29436000,
    "currentleaseliabilities": 6401000,
    "noncurrentleaseliabilities": 23035000,
    "propertyplantandequipment": 16739000,
    "othercurrentassets": 11953000,
    "assets": 5717731000,
    "retainedearnings": -334701000,
    "deferredincomeclassifiedascurrent": 443159000,
    "equityandliabilities": 5717731000,
    "ifrsnumberofreportablesegments": 1,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P3Y",
    "percentageofseniormanagementbonusschemepaidimmediatelyaroundyearend": 0.5,
    "remainingpercentageofseniormanagementbonusschemepaiddeferredforthreeyears": 0.5,
    "bounsplanremainderpercentagedueamortizationperiod": "P3Y",
    "fornextbiotechindexversusgalapagossharepricethresholdfordeferredbounspaymenttobeadjusted": 0.1,
    "fornextbiotechindexversusgalapagossharepricethresholdfordeferredbounspaymenttobeforfeited": 0.1,
    "percentageofentitysrevenue": 0.99,
    "noncurrentassetsotherthanfinancialinstrumentsdeferredtaxassetspostemploymentbenefitassetsandrightsarisingunderinsurancecontracts": 171000000,
    "revenuefromgovernmentgrants": 5452000,
    "researchanddevelopmentincentiveincome": 45951000,
    "miscellaneousotheroperatingincome": 804000,
    "generalandadministrativepersonnelcosts": 70110000,
    "generalandadministrativedepreciationexpenses": 5147000,
    "generalandadministrativelegalandprofessionalfees": 25592000,
    "generalandadministrativeotheroperatingexpenses": 17908000,
    "salesandmarketingpersonnelcosts": 31727000,
    "salesandmarketingdepreciationexpenses": 140000,
    "salesandmarketingexternaloutsourcingcosts": 27174000,
    "salesandmarketingprofessionalfeesexpenses": 3420000,
    "salesandmarketingotheroperatingexpenses": 4007000,
    "wagesandsalaries": 139681000,
    "socialsecuritycontributions": 26471000,
    "postemploymentbenefitexpensedefinedcontributionplansanddefinedbenefitplans": 7337000,
    "otherpersonnelcostswarrantsgranted": 79959000,
    "otheremployeeexpense": 9897000,
    "employeebenefitsexpense": 263345000,
    "equity": 2670355000,
    "comprehensiveincome": -2047000,
    "increasedecreasethroughsharebasedpaymenttransactions": 79959000,
    "increasedecreasethroughexerciseofwarrantsequity": 4031000,
    "interestincomeondeposits": 10030000,
    "effectofdiscountinglongtermresearchanddevelopmentincentivesreceivables": 93000,
    "netforeignexchangegain": 4697000,
    "gainslossesonfinancialassetsatfairvaluethroughprofitorloss": 2397000,
    "miscellaneousotherfinanceincome": 1450000,
    "interestexpense": 9389000,
    "effectofdiscountinglongtermdeferredincome": 16278000,
    "netforeignexchangeloss": 110416000,
    "lossesondisposalorsaleoffinancialassetsatfairvaluethroughprofitorloss": 88000,
    "fairvaluelossoncurrentfinancialinvestments": 15901000,
    "miscellaneousotherfinanceexpense": 773000,
    "otherfinanceincomecost": -134177000,
    "currenttaxliabilitiescurrent": 1248000,
    "currenttaxliabilities": 1248000,
    "taxexpenseincomeatapplicabletaxrate": -77444000,
    "differenceintaxexpenseincomebetweenstatutoryandeffectivetaxrate": 78670000,
    "taxeffectofforeigntaxrates": 184000,
    "taxeffectofrevenuesexemptfromtaxation2011": 10196000,
    "effectofsharebasedpaymentexpenseswithouttaximpact": 19990000,
    "taxeffectofexpensesincomenotsubjecttotax": -639000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 1053000,
    "taxeffectofrecognitionofpreviouslynonrecognizeddeferredtaxassets": -475000,
    "taxeffectfromtaxlossesutilizedreversed": -150000,
    "taxeffectfromunderoverprovisionpriorperiods": -25000,
    "taxeffectfromnonrecognitionofdeferredtaxassets": 69141000,
    "taxeffectofderecognitionofpreviouslyrecognizeddeferredtaxassets": 157000,
    "taxeffectofuseofinvestmentdeduction": 370000,
    "amountofdifferencesintaxexpenseincomebetweenstatutoryandeffectiverateexplained": 78670000,
    "applicabletaxrate": 0.25,
    "increasedecreaseineffectivetaxrateduetouseofinnovationincomededuction": 0.0375,
    "profitlossattributabletoordinaryequityholdersofparententity": -305436000,
    "intangibleassetsotherthangoodwill": 67565000,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 9494000,
    "amortisationintangibleassetsotherthangoodwill": 2303000,
    "disposalsandretirementsintangibleassetsotherthangoodwill": 17000,
    "decreasethroughclassifiedasheldforsaleintangibleassetsotherthangoodwill": 159000,
    "increasedecreasethroughnetexchangedifferencesintangibleassetsotherthangoodwill": -143000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 885000,
    "depreciationpropertyplantandequipment": 654000,
    "disposalspropertyplantandequipment": 51000,
    "increasedecreasethroughtransferspropertyplantandequipment": 10625000,
    "decreasethroughclassifiedasheldforsalepropertyplantandequipment": 2000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": -2000,
    "rightofuseassets": 39678000,
    "additionstorightofuseassets": 18341000,
    "depreciationrightofuseassets": 5350000,
    "disposalsrightofuseassets": 6000,
    "decreasethroughclassifiedasheldforsalerightofuseassets": 5940000,
    "increasedecreasethroughnetexchangedifferencesrightofuseassets": -88000,
    "propertyplantandequipmentincludingrightofuseassets": 103378000,
    "noncurrentrestrictedcashandcashequivalents": 1482000,
    "financialassetsatfairvaluethroughprofitorloss": 8951000,
    "othermiscellaneousnoncurrentassets": 910000,
    "othernoncurrentassets": 11343000,
    "financialassetsatfairvaluethroughprofitorlossmandatorilymeasuredatfairvalue": 3910000,
    "purchasesfairvaluemeasurementassets": 1994000,
    "salesfairvaluemeasurementassets": 2820000,
    "fairvalueadjustmentoffinancialassets": 5042000,
    "gainslossesrecognisedinprofitorlossfairvaluemeasurementassets": -3894000,
    "increasedecreaseinfairvaluemeasurementassets": 2397000,
    "noncurrentresearchanddevelopmentincentivesreceivables": 111624000,
    "currentresearchanddevelopmentincentivesreceivables": 24104000,
    "researchanddevelopmentincentivesreceivables": 135728000,
    "noncurrenttradereceivables": 50000000,
    "currenttradereceivables": 134632000,
    "currentprepayments": 219000,
    "othercurrentreceivables": 13568000,
    "tradeandothercurrentreceivables": 148418000,
    "inventories": 355000,
    "currentaccruedincome": 1096000,
    "currentdeferredcharges": 10502000,
    "tradeandotherreceivablesandothercurrentasset": 210371000,
    "treasurybillsatcarryingvaluecurrent": 1454400000,
    "moneymarketfundsatcarryingvaluecurrent": 1571900000,
    "currentfinancialinvestmentssubjecttoforeigncurrencyexchangegainorloss": 524600000,
    "shorttermdepositsclassifiedascashequivalents": 895194000,
    "cashandcashequivalentssubjecttoforeigncurrencyexchangegainorloss": 894300000,
    "maturityperiod": "P3M",
    "increasedecreaseinsharecapitalexcludingissuancepremium": 4031000,
    "aggregatesharecapitalaftertransaction": 353819000,
    "accumulatedcostofcapitalincrease": 62507000,
    "increaseinsharecapitalduetoissuanceofwarrants": 824000,
    "numberofsharesissued": 152,
    "aggregatenumberofsharesaftertransaction": 65412,
    "numberofsharesissuedandfullypaid": 65411767,
    "issuedcapital": 291312000,
    "sharepremium": 2727840000,
    "numberofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement": 152220,
    "weightedaverageexercisepriceofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement2019": 35.18,
    "closingsharepriceondateofcapitalincrease": 141.4,
    "parvaluepershare": 5.41,
    "authorizationtermofboardofdirectors": "P5Y",
    "remainingbalanceofgeneralpartofauthorizedcapitalavailable": 55264659690,
    "remainingbalanceofspecificpartofauthorizedcapitalavailable": 13717929800,
    "taxattributesanddeductibletemporarydifferences": 1485800000,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 256500,
    "taxlossescarriedforwardanddeductibletemporarydifferences": 1229300000,
    "taxlossescarriedforward": 478600000,
    "carriedforwardtaxdeductiontobeoffsetagainstfutureincome": 247200000,
    "deferredtaxassets": 4475000,
    "numberofsubsidiariesoperatingoncostplusbasisforwhichdeferredtaxassetswererecognized": 4,
    "leasepaymentspayableundernoncancelableoperatingleaseias17": 6772000,
    "leasepaymentspayableatpresentvalue": 6401000,
    "futurefinancechargeonleaseliabilities": 949000,
    "tradeandotherpayables": 171316000,
    "othernoncurrentliabilities": 8096000,
    "accrualsclassifiedascurrent": 1070000,
    "totaltradeandotherliabilities": 180482000,
    "deferredincome": 818700000,
    "deferredincomeclassifiedasnoncurrent": 2365974000,
    "adjustmentsfordepreciationandamortisationexpense": 18682000,
    "adjustmentsforsharebasedpayments": 79959000,
    "adjustmentsforincreasedecreaseinemployeebenefitliabilities": -260000,
    "adjustmentsforunrealizedforeignexchangelossesgainsandnoncashotherfinancialexpenses": 105055000,
    "adjustmentsfordiscountingeffectofdeferredincome": 16278000,
    "adjustmentsforfairvalueremeasurementofsharesubscriptionagreementandwarrants": -3034000,
    "netfairvalueadjustmentrelatingtocurrentfinancialinvestments": 15900000,
    "adjustmentsforfairvaluelossgainonfinancialassetsheldatfairvaluethroughprofitorloss": -2396000,
    "adjustmentforothernoncashexpenses": 539000,
    "adjustmentsforinterestexpense": 9424000,
    "adjustmentsforinterestincome": 7476000,
    "adjustmentsforincometaxexpense": 2119000,
    "adjustmentsforlossesgainsondisposalofnoncurrentassets": 82000,
    "proceedsfrominterestreceivedrelatedtocurrentfinancialinvestments": -2554000,
    "adjustmentsfordecreaseincreaseininventories": -100000,
    "adjustmentsfordecreaseincreaseintradeaccountreceivable": -177155000,
    "adjustmentsforincreasedecreaseintradeaccountpayable": 31163000,
    "purchasecommitments": 347873000,
    "contractualobligationscommitments": 493400000,
    "proportionofvotingpowerheldinsubsidiary": 1,
    "tieredroyaltiespercentageonnetsales": 0.2,
    "costshareforglobaldevelopmentactivities": 0.5,
    "potentialdevelopmentmilestonepayment": 295000000,
    "salesbasedmilestonepaymentstobereceived": 600000000,
    "percentageoffuturenetsalesfrom2024": 0.08,
    "amountsreceivablerelatedpartytransactions": 160000000,
    "upfrontpaymentsreceivablerelatedpartytransactionsinnextfiscalyear": 75000000,
    "upfrontpaymentsreceivablerelatedpartytransactionsinyeartwo": 50000000,
    "percentageofotherequityinstrumentsvested": 0.25,
    "ifrssharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod": "P4Y",
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 79959000,
    "weightedaverageexercisepriceofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement2019": 7.12,
    "weightedaverageremainingcontractuallifeoutstandingofotherequityinstruments": "P2050D",
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 1365,
    "numberofinstrumentsotherequityinstrumentsgranted": 1925185,
    "numberofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement": 2000,
    "numberofotherequityinstrumentsexercisedinsharebasedpaymentarrangement": 1050,
    "numberofotherequityinstrumentsexercisableinsharebasedpaymentarrangement": 1365,
    "weightedaverageexercisepriceofotherequityinstrumentsgrantedinsharebasedpaymentarrangement2019": 168.4,
    "weightedaverageexercisepriceofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement2019": 144.8,
    "weightedaverageexercisepriceofotherequityinstrumentsexercisableinsharebasedpaymentarrangement2019": 37.8,
    "exercisepriceotherequityinstrumentsgranted": 168.42,
    "weightedaveragesharepriceatacceptancedate": 178.95,
    "weightedaveragefairvalueatacceptancedate": 86.45,
    "weightedaverageestimatedvolatilityrate": 0.513,
    "weightedaverageexpectedlifeofsubscriptionrights": "P6Y",
    "weightedaverageriskfreerate": -0.0044,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 3102000,
    "keymanagementpersonnelcompensationshorttermemployeebenefitsgrosssalary": 2531000,
    "keymanagementpersonnelcompensationshorttermemployeebenefitscashbonus": 433000,
    "keymanagementpersonnelcompensationshorttermemployeebenefitsothershorttermbenefits": 138000,
    "keymanagementpersonnelcompensationboardfeesandothershorttermbenefitsfordirectors": 220000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 392000,
    "keymanagementpersonnelcompensation": 4262000,
    "numberofinstrumentsotherequityinstrumentsgrantedexcludingdeferredportionofbonus": 18317,
    "keymanagementpersonnelcompensationsharebasedpayment": 22921000,
    "financialassetsatamortisedcost": 1454420000,
    "financialliabilitiesatfairvaluethroughprofitorloss": 3164000,
    "financialliabilitiesatamortisedcost": 134905000,
    "percentageofreasonablypossibleincreaseinriskassumption": 0.01,
    "percentageofreasonablypossibledecreaseinriskassumption": 0.01,
    "increasedecreaseinprofitorlossandequityduetoreasonablypossibleincreasedecreaseinnumberof100basispoints": 51700000,
    "increasedecreaseinnetbookvalueduetoreasonablypossiblechangeindesignatedriskcomponent": -116690000,
    "auditorsremunerationforauditservices": 1202800,
    "auditorsremunerationforperformanceofauditorreviewofcompanysaffiliatesfinancialstatements": 23900,
    "feesforservicesexecutedforcompanysaffiliates": 29200,
    "auditorsremunerationforotherfeesrelatedtoauditrelatedgeneralfees": 161300,
    "otherfeesrelatedtononauditservicesexecutedbystatutoryauditor.": 47700,
    "otherfeesrelatedtononauditservicesexecutedbypersonsrelatedtostatutoryauditor.": 890700,
    "deferredtaxassetsunrecognized": 365639000,
    "deferredtaxexpenseincomerecognisedinprofitorloss": 157000,
    "taxbenefitarisingfrompreviouslyunrecognisedtaxlosstaxcreditortemporarydifferenceofpriorperiodusedtoreducedeferredtaxexpense": 581000,
    "deferredtaxexpenseincomerelatingtooriginationandreversaloftemporarydifferences": -44000,
    "deferredtaxexpensearisingfromwritedownorreversalofwritedownofdeferredtaxasset": -695000,
    "noncurrentassets": 348384000,
    "currentassetsotherthanassetsordisposalgroupsclassifiedasheldforsaleorasheldfordistributiontoowners": 5345941000,
    "noncurrentassetsordisposalgroupsclassifiedasheldforsale": 23406000,
    "currentassets": 5369347000,
    "otherreserves": -10907000,
    "reserveofexchangedifferencesontranslation": -3189000,
    "noncurrentrecognisedliabilitiesdefinedbenefitplan": 14996000,
    "noncurrentliabilities": 2412101000,
    "tradeandothercurrentpayables": 172386000,
    "currentliabilitiesotherthanliabilitiesincludedindisposalgroupsclassifiedasheldforsale": 626357000,
    "liabilitiesincludedindisposalgroupsclassifiedasheldforsale": 8917000,
    "currentliabilities": 635274000,
    "liabilities": 3047375000,
    "upfrontpayments": 160000000,
    "milestonepaymentsreceived": 90192000,
    "deferredincomesignificantfinancingcomponent": 16278000,
    "upfrontorlicensefeesrevenuerecognised": -411417000,
    "milestonepaymentsrevenuerecognized": -46261000,
    "increasedecreaseinotherdeferredincome": -305000,
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": "P5Y",
    "documenttype": "20-F",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "documentperiodenddate": "2020-12-31",
    "entityregistrantname": "GALAPAGOS NV",
    "entitycommonstocksharesoutstanding": 65411767,
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1421876,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "entityfilenumber": "001-37384",
    "entityincorporationstatecountrycode": "C9",
    "documentaccountingstandard": "U.S. GAAP",
    "entityaddressaddressline1": "Generaal De Wittelaan L11 A3",
    "entityaddresscityortown": "Mechelen",
    "entityaddresspostalzipcode": 2800,
    "entityaddresscountry": "BE",
    "contactpersonnelfaxnumber": "32 15 342 901",
    "contactpersonnelname": "Onno van de Stolpe",
    "profitlossbeforetaxdiscontinuedoperations": 6458000,
    "taxexpenserelatingtoprofitlossfromordinaryactivitiesofdiscontinuedoperations": 893000,
    "basicearningslosspersharefromdiscontinuedoperations": 0.09,
    "dilutedearningslosspersharefromdiscontinuedoperations": 0.08,
    "cashflowsfromusedinoperatingactivitiesdiscontinuedoperations": 7173000,
    "cashflowsfromusedininvestingactivitiesdiscontinuedoperations": -2284000,
    "cashflowsfromusedinfinancingactivitiesdiscontinuedoperations": -664000,
    "increasedecreaseincashandcashequivalentsdiscontinuedoperations": 4225000,
    "netassetsliabilities": 14488000,
    "balanceswithbanks": 1239993000,
    "numberofpersonnelrelatedtocontinuingoperations": 1304,
    "numberofemployees": 185,
    "researchanddevelopmentpersonnelcosts": 161509000,
    "researchanddevelopmentsubcontracting": 301841000,
    "researchanddevelopmentdisposablesandlabfeesandpremisescosts": 22349000,
    "researchanddevelopmentdepreciationexpenses": 11707000,
    "researchanddevelopmentprofessionalfeesexpenses": 12692000,
    "researchanddevelopmentotheroperatingexpenses": 13570000,
    "futureglobaldevelopmentcostssharingratiobeforepredeterminedlevel": 0.2,
    "amountsreceivablerelatedpartytransactionsinnexttwelvemonths": 110000000,
    "amountsreceivablerelatedpartytransactionsyeartwo": 50000000,
    "upfrontpaymentsreceivable": 35000000,
    "proportionofownershipinterestinassociate": 0.2554,
    "numberofotherequityinstrumentspaidincashinsharebasedpaymentarrangement": 27268,
    "numberofsecuritiescalledbyeachrestrictedstockorright": 1,
    "numberofcalendardaysperiodprecedingvestingdateforcalculatevalueofweightedaveragepriceofentitysharetradedonstockexchange": 30,
    "percentageofotherequityinstrumentsvestedincertainperiod": 0.5,
    "numberofcalendardaysperiodprecedingreportingperiodforcalculatevalueofweightedaveragepriceofentitysharetradedonstockexchange": 30,
    "numberofperformanceobligation": 3,
    "periodrecognizedtoconsiderationpaidforplatform": "P10Y",
    "purchasecommitmentsterm": "P5Y",
    "changeinownershipinterest": -1,
    "revenuefromsaleofgoods": 2000,
    "revenuefromroyalties": 16227000,
    "otherrevenuefromcommercialactivities": 2000,
    "numberofexecutivecommitteemembers": 6,
    "numberofboardofdirectors": 8,
    "percentageofownershipinterest": 0.2554,
    "numberofcapitalincreases": 4,
    "noncurrenttradereceivablesrelatedpartytransactions": 50000000,
    "tradeandotherreceivablesrelatedpartytransactions": 132825000,
    "amountspayablerelatedpartytransactions": 27074000,
    "crosschargespayablerelatingtodevelopmentoffilgotinib": 24800,
    "impactonrevenuesfromperformanceobligations": 229600000,
    "totalimpactonrevenue": 228100000,
    "costreimbursementsrecognized": 34100000,
    "increasedecreaseinsalesandmarketingexpesnes": -4700000,
    "increasedecreaseinresearchanddevelopmentexpesnes": -3100000,
    "transactionpriceallocatedtoremainingperformanceobligations": 666967000,
    "upfrontconsideration": 4005373000,
    "collaborationagreementconsiderationassharesubscription": 124604000,
    "collaborationagreementtotaltransactionprice": 106419000,
    "warrantsissuanceliabilities": 43311000,
    "fairvalueofwarrantsissuanceliabilities": 7900000,
    "collaborationagreementestimatedsignificantfinancingcomponentvalue": 55300000,
    "periodoverwhichdrugdiscoveryprogramrevenueisrecognized": "P101010Y",
    "maximumextensionperiodforspecificprogram": "P3Y"
  }
]